Within Medical Equipment & Supplies industry Achari Ventures Holdings Corp I booked the highest Quick Ratio than Achari Ventures Holdings I in the second quarter 2024. While total ranking remained the same in the Q2 2024 compared to the first quarter 2024 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents AVHI�s has?
What are AVHI�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AVHI Quick Ratio	(Jun 30 2024) Q2	(Mar 31 2024) Q1	(Dec 31 2023) Q4	(Sep 30 2023) Q3	(Jun 30 2023) Q2
Y / Y Current Liabilities Change	101.24 %	126.3 %	-90.82 %	531 %	929.46 %
Y / Y Cash & cash equivalent Change	-	-	-91.9 %	-95.65 %	-97.88 %
Quick Ratio MRQ	-	-	0.01	0.01	0
AVHI's Total Ranking	#	#	#	#	#
Seq. Current Liabilities Change	19.49 %	47.99 %	-1.18 %	15.16 %	34.36 %
Seq. Cash & cash equivalent Change	-	-	157.31 %	133.49 %	-90.11 %

Quick Ratio second quarter 2024 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	#
Healthcare Sector	#
Overall Market	#

Quick Ratio Statistics
High	Average	Low
0	0	0

Financial Statements
Achari Ventures Holdings I's Current Liabilities	$ 6 Millions	Visit AVHI's Balance sheet
Achari Ventures Holdings I's Cash & cash equivalent	$ 0 Millions	Visit AVHI's Balance sheet
Source of AVHI's Sales		Visit AVHI's Sales by Geography

Cumulative Achari Ventures Holdings I's Quick Ratio

AVHI's Quick Ratio for the trailling 12 Months

AVHI Quick Ratio	(Jun 30 2024) 12 Months	(Mar 31 2024) 12 Months	(Dec 31 2023) 12 Months	(Sep 30 2023) 12 Months	(Jun 30 2023) 12 Months
Y / Y Current Liabilities TTM Growth	-58.19 %	-62.92 %	-68.41 %	3651.22 %	5871.01 %
Y / Y Cash & cash equivalent TTM Growth	-93.99 %	-94.95 %	-92.25 %	-67.9 %	-37.01 %
Quick Ratio TTM	0	0.01	0.01	0.02	0.03
Total Ranking TTM	# 3729	# 3678	# 4054	# 4024	#
Seq. Current Liabilities TTM Growth	20.35 %	23.3 %	-73.61 %	6.77 %	6.73 %
Seq. Cash & cash equivalent TTM Growth	-10.7 %	-51.99 %	-77.79 %	-36.94 %	-24.91 %

Quick ratio ranking by company, industry and sector >> Back to AVHI Financial Strength Comparisons >> Go to Compare AVHI Quick Ratio to its Competitors

On the trailing twelve months basis Due to unchanged in Current Liabilities in the Q2 2024 to $5.74 millions, cumulative Quick Ratio decreased to 0 below the Achari Ventures Holdings Corp I average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 223 other companies have achieved higher Quick Ratio than Achari Ventures Holdings I. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2024 from 3678 to 3729.

Explain Quick Ratio?
How much Cash & cash equivalents AVHI�s has?
What are AVHI�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 224
Healthcare Sector	# 986
Within the Market	# 3729

trailing twelve months Quick Ratio Statistics
High	Average	Low
3.27	1.41	0
(Mar 31 2018)		(Jun 30 2024)

Companies with similar Quick Ratio in the quarter ending Jun 30 2024, within Medical Equipment & Supplies Industry

Quick Ratio

Jun 30 2024 MRQ Cash & cash equivalent

Jun 30 2024 MRQ Current Liabilities

Date modified: 2026-09-26T07:41:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.